The world market for recombinant proteins remains strong, with North America and Europe dominating research and development as a result of their strong biopharmaceutical industries. The Asia-Pacific ...

We are repeating this editorial, originally published in January this year, as an appeal to Nigerian experts to rein in their ...

Gene editing can cure illnesses, ensure global food security, conserve species and more. But its risks of misuse are ...

Quadrivalent and high-dose vaccines offer diverse demographic needs, while digital platforms aid vaccine monitoring and distribution. A robust government backing, ongoing research and development, and ...

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This rep ...

Current techniques of gene transfer in mammals include packaging the DNA into recombinant viral vectors ... to test if they have created an effective vaccine. In addition, naked DNA vaccines ...

We discuss inactivated vaccines, virally and bacterially vectored vaccines, recombinant protein and DNA vaccines, as well as the use of attenuated vaccines. Data regarding the correlates of ...

Addressing ongoing public skepticism about genetically modified organisms (GMOs), Dr. Salako firmly debunked myths linking ...

He highlighted that DNA recombinant technology for vaccine production and regenerative medicine are some of the areas where biotechnology is already contributing to national health goals, particularly ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...